Advertisement
Home Tags Respiratory Problems: Misc.

Tag: Respiratory Problems: Misc.

For individuals with obstructive sleep apnea

Short Respiratory Event Duration Ups Mortality Risk in OSA

0
Individuals with shortest-duration events had adjusted hazard ratio of 1.31 for all-cause mortality

American College of Chest Physicians, Oct. 6-10

0
The 84th Annual Meeting of the American College of Chest Physicians The annual meeting of the American College of Chest Physicians was held...
Profiles of childhood respiratory risk factors predict middle-age lung function levels and chronic obstructive pulmonary disease risk

Childhood Risk Profiles Affect Middle-Age Lung Function

0
Children with frequent asthma, allergies who smoke as adults are most vulnerable group
Red tide may be the reason why some beachgoers on Florida's Atlantic coast have suffered breathing problems

Red Tide May Be Cause of Florida Beachgoers’ Breathing Problems

0
Red tide can cause symptoms such as breathing problems as well as skin and throat irritation
In a direct-to-consumer telemedicine setting

Telemedicine RTI Visits Shorter When Antibiotic Prescribed

0
Finding may highlight physician difficulty explaining to patients why antibiotics are not required

September 2018 Briefing – Pulmonology

0
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for September 2018. This roundup includes the latest...
Laparoscopic antireflux surgery is safe and well-tolerated in patients with idiopathic pulmonary fibrosis and abnormal acid gastroesophageal reflux

Anti-Reflux Surgery Promising in Idiopathic Pulmonary Fibrosis

0
In phase 2 study, surgery for abnormal acid GER in IPF patients was safe, well-tolerated
Arikayce (amikacin liposome inhalation suspension) has been approved by the U.S. Food and Drug Administration to treat lung disease caused by Mycobacterium avium complex bacteria among patients who do not respond to conventional therapies

FDA Approves New Drug for Antibiotic-Resistant Lung Disease

0
Arikayce approved to treat lung disease caused by Mycobacterium avium complex bacteria
Nintedanib plus sildenafil does not provide benefit over nintedanib alone for patients with idiopathic pulmonary fibrosis and diffusion capacity of the lungs for carbon monoxide of 35 percent or less of the predicted value

Nintedanib Plus Sildenafil No Better Than Nintedanib in IPF

0
No benefit with sildenafil in idiopathic pulmonary fibrosis with severe impairment in gas exchange
For older Korean women

Grip Strength Tied to Pulmonary Function in Older Women

0
Dose-dependent positive association seen in cohort of community-dwelling Korean women aged ≥65